Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsDividends payablesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Non-Current Assets (2020 - 2025)

Selectis Health's Non-Current Assets history spans 10 years, with the latest figure at $29.3 million for Q3 2025.

  • For Q3 2025, Non-Current Assets fell 3.58% year-over-year to $29.3 million; the TTM value through Sep 2025 reached $118.7 million, down 10.25%, while the annual FY2024 figure was $29.9 million, 16.23% down from the prior year.
  • Non-Current Assets for Q3 2025 was $29.3 million at Selectis Health, down from $29.6 million in the prior quarter.
  • Across five years, Non-Current Assets topped out at $46.3 million in Q1 2022 and bottomed at $29.3 million in Q3 2025.
  • The 5-year median for Non-Current Assets is $36.8 million (2023), against an average of $35.6 million.
  • The largest annual shift saw Non-Current Assets rose 18.38% in 2022 before it dropped 19.67% in 2023.
  • A 5-year view of Non-Current Assets shows it stood at $39.0 million in 2021, then decreased by 3.67% to $37.5 million in 2022, then fell by 4.83% to $35.7 million in 2023, then dropped by 16.23% to $29.9 million in 2024, then dropped by 2.03% to $29.3 million in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Non-Current Assets are $29.3 million (Q3 2025), $29.6 million (Q2 2025), and $29.8 million (Q1 2025).